Active Ingredient
Lidocaine HCI 4%
The following Structured Product Label (SPL) was submitted to the FDA by Chattem, Inc. for the product Aspercreme With Lidocaine Pain Relieving Creme (NDC 41167-0582). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Lidocaine HCI 4%
Topical anesthetic
temporarily relieves minor pain
For external use only
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
adults and children over 12 years:
children 12 years and younger: ask a doctor
acrylates/C10-30 alkyl acrylate crosspolymer, aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, methylparaben, SD alcohol 40 (15%), steareth-21, water (309-124)
* Please review the disclaimer below.